LIVE·NEON · 1,211 CONTRACTS
ContractLocal CCP

H2593·Elevance Health, Inc.

HMO/HMOPOS · observed 2026 → 2026 · 75 months of CPSC history · 19 active CY 2025 plans.

Latest enrollment
11.3K
2026-05
93.1K vs 2020-11 peak
Months of data
75
History range
2020-01 → 2026-05
CY 2025 plans
19
01 · Trend

Monthly enrollment

fact_enrollment_cpsc · 75 months
104,4154,700
02 · Plans

CY 2025 plan roster

fact_landscape ⋈ fact_enrollment_cpsc · 19 plans
PlanCategoryPremiumMOOPCountiesEnrollment
Wellpoint Full Dual Advantage 2 (HMO D-SNP)
H2593/051 · Dual-Eligible
SNP$18$9,3503.581,527
Wellpoint Full Dual Advantage Aligned (HMO D-SNP)
H2593/046 · Dual-Eligible
SNP$0$9,3503.5921,523
Wellpoint Medicare Advantage 2 (HMO-POS)
H2593/029
MA-PD$0$9,3503.5831,444
Wellpoint Dual Advantage 2 (HMO D-SNP)
H2593/032 · Dual-Eligible
SNP$0$9,3503.5841,332
Wellpoint Full Dual Advantage Aligned (HMO D-SNP)
H2593/047 · Dual-Eligible
SNP$7$9,3503.515529
Wellpoint Full Dual Advantage (HMO D-SNP)
H2593/053 · Dual-Eligible
SNP$0$9,3503.52400
Wellpoint Full Dual Advantage Aligned (HMO D-SNP)
H2593/044 · Dual-Eligible
SNP$15$9,3503.511353
Wellpoint Full Dual Advantage Aligned (HMO D-SNP)
H2593/045 · Dual-Eligible
SNP$18$9,3503.514334
Wellpoint Kidney Care (HMO-POS C-SNP)
H2593/043 · Chronic or Disabling Condition
SNP$0$2,9003.556240
Wellpoint Kidney Care (HMO-POS C-SNP)
H2593/031 · Chronic or Disabling Condition
SNP$0$8,3003.56108
Wellpoint Full Dual Advantage 2 (HMO D-SNP)
H2593/048 · Dual-Eligible
SNP$18$9,3503.5927
Wellpoint Medicare Advantage 2 (HMO-POS)
H2593/001
MA-PD$0$8,3003.510
Wellpoint I Carelon Home Care 2 (HMO I-SNP)
H2593/003 · Institutional
SNP$0$2,7003.520
Wellpoint Lung Care 2 (HMO-POS C-SNP)
H2593/005 · Chronic or Disabling Condition
SNP$0$8,3003.510
Wellpoint Chronic Care 2 (HMO-POS C-SNP)
H2593/006 · Chronic or Disabling Condition
SNP$0$8,3003.510
Wellpoint I Carelon Kidney Care (HMO-POS C-SNP)
H2593/040 · Chronic or Disabling Condition
SNP$0$3,0003.510
Wellpoint Full Dual Advantage 2 (HMO D-SNP)
H2593/049 · Dual-Eligible
SNP$9$9,3503.520
Wellpoint Full Dual Advantage 2 (HMO D-SNP)
H2593/054 · Dual-Eligible
SNP$12$9,3503.560
Wellpoint Full Dual Advantage 2 (HMO D-SNP)
H2593/056 · Dual-Eligible
SNP$8$9,3503.570
03 · Quality

Star Ratings · contract-level

fact_star_ratings · 2 years
Star scale · 1.0 – 5.0★ summary
1.02.03.04.05.0202520263.53.53.03.03.53.5
  • Overall
    3.53.5
    0.020252026
  • Part C
    3.03.0
    0.020252026
  • Part D
    3.53.5
    0.020252026
Measure breakdown · CY 2025 · 42 measures
IDMeasure
C01Breast Cancer Screening2.0
C02Colorectal Cancer Screening2.0
C03Annual Flu Vaccine3.0
C04Monitoring Physical Activity3.0
C05Special Needs Plan (SNP) Care Management1.0
C06Care for Older Adults � Medication Review4.0
C07Care for Older Adults � Pain Assessment3.0
C08Osteoporosis Management in Women who had a Fracture
C09Diabetes Care � Eye Exam2.0
C10Diabetes Care � Blood Sugar Controlled3.0
C11Controlling High Blood Pressure1.0
C12Reducing the Risk of Falling4.0
C13Improving Bladder Control1.0
C14Medication Reconciliation Post-Discharge3.0
C15Plan All-Cause Readmissions3.0
C16Statin Therapy for Patients with Cardiovascular Disease2.0
C17Transitions of Care1.0
C18Follow-up after Emergency Department Visit for People with Multiple High-Risk Chronic Conditions2.0
C19Getting Needed Care
C20Getting Appointments and Care Quickly
C21Customer Service
C22Rating of Health Care Quality
C23Rating of Health Plan2.0
C24Care Coordination
C25Complaints about the Health Plan4.0
C26Members Choosing to Leave the Plan3.0
C27Health Plan Quality Improvement4.0
C28Plan Makes Timely Decisions about Appeals5.0
C29Reviewing Appeals Decisions4.0
C30Call Center � Foreign Language Interpreter and TTY Availability5.0
D01Call Center � Foreign Language Interpreter and TTY Availability5.0
D02Complaints about the Drug Plan4.0
D03Members Choosing to Leave the Plan3.0
D04Drug Plan Quality Improvement4.0
D05Rating of Drug Plan
D06Getting Needed Prescription Drugs
D07MPF Price Accuracy3.0
D08Medication Adherence for Diabetes Medications2.0
D09Medication Adherence for Hypertension (RAS antagonists)2.0
D10Medication Adherence for Cholesterol (Statins)2.0
D11MTM Program Completion Rate for CMR3.0
D12Statin Use in Persons with Diabetes (SUPD)3.0